Clinical Trial Update: Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating RD03/2016 for the treatment of bacterial conjunctivitis in adults has completed, assessing its effects and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• RD03/2016

Snippet

Sponsor: NTC srl | Conditions: Conjunctivitis, Bacterial | Phase 2 | Status: COMPLETED